PA8475901A1 - Terapia de combinacion para la fragilidad musculoesqueletica - Google Patents

Terapia de combinacion para la fragilidad musculoesqueletica

Info

Publication number
PA8475901A1
PA8475901A1 PA19998475901A PA8475901A PA8475901A1 PA 8475901 A1 PA8475901 A1 PA 8475901A1 PA 19998475901 A PA19998475901 A PA 19998475901A PA 8475901 A PA8475901 A PA 8475901A PA 8475901 A1 PA8475901 A1 PA 8475901A1
Authority
PA
Panama
Prior art keywords
fragility
compositions
fenil
oxo
combination therapy
Prior art date
Application number
PA19998475901A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8475901A1 publication Critical patent/PA8475901A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PA19998475901A 1998-06-16 1999-06-15 Terapia de combinacion para la fragilidad musculoesqueletica PA8475901A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
PA8475901A1 true PA8475901A1 (es) 2000-05-24

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19998475901A PA8475901A1 (es) 1998-06-16 1999-06-15 Terapia de combinacion para la fragilidad musculoesqueletica

Country Status (30)

Country Link
EP (1) EP1087764A1 (ru)
JP (1) JP2002518326A (ru)
KR (1) KR20010052852A (ru)
CN (1) CN1301160A (ru)
AP (1) AP9901582A0 (ru)
AR (1) AR018869A1 (ru)
AU (1) AU4054799A (ru)
BG (1) BG105041A (ru)
BR (1) BR9911324A (ru)
CA (1) CA2335134A1 (ru)
CO (1) CO5070587A1 (ru)
EA (1) EA200001186A1 (ru)
GT (1) GT199900087A (ru)
HN (1) HN1999000097A (ru)
HR (1) HRP20000859A2 (ru)
HU (1) HUP0102505A3 (ru)
ID (1) ID27599A (ru)
IL (1) IL138630A0 (ru)
IS (1) IS5691A (ru)
MA (1) MA26652A1 (ru)
NO (1) NO20006312L (ru)
OA (1) OA11505A (ru)
PA (1) PA8475901A1 (ru)
PE (1) PE20000646A1 (ru)
PL (1) PL344981A1 (ru)
SK (1) SK18912000A3 (ru)
TN (1) TNSN99124A1 (ru)
TR (1) TR200003544T2 (ru)
WO (1) WO1999065486A1 (ru)
ZA (1) ZA993975B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (ru) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)Цис-6(S)-фенил-5(R)-[4-(2-пирРолидин-1-илетокси)фенил]-5,6,7,8-тетрагидронафталин-2-ол D-тартрат, способ его получения, способы лечения заболеваний поддающихся лечению агонистами эстрогена, и фармацевтическая композиция
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID27599A (id) 2001-04-12
CO5070587A1 (es) 2001-08-28
JP2002518326A (ja) 2002-06-25
NO20006312D0 (no) 2000-12-12
OA11505A (en) 2004-05-07
ZA993975B (en) 2000-12-15
PL344981A1 (en) 2001-11-19
HUP0102505A3 (en) 2002-12-28
HRP20000859A2 (en) 2001-04-30
GT199900087A (es) 2000-12-07
TNSN99124A1 (fr) 2005-11-10
TR200003544T2 (tr) 2001-04-20
KR20010052852A (ko) 2001-06-25
NO20006312L (no) 2000-12-12
PE20000646A1 (es) 2000-08-05
CN1301160A (zh) 2001-06-27
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
CA2335134A1 (en) 1999-12-23
AR018869A1 (es) 2001-12-12
EP1087764A1 (en) 2001-04-04
BG105041A (en) 2001-08-31
MA26652A1 (fr) 2004-12-20
SK18912000A3 (sk) 2001-10-08
AP9901582A0 (en) 1999-06-30
EA200001186A1 (ru) 2001-06-25
WO1999065486A1 (en) 1999-12-23
IS5691A (is) 2000-10-27
AU4054799A (en) 2000-01-05
BR9911324A (pt) 2001-04-03
HN1999000097A (es) 1999-11-03

Similar Documents

Publication Publication Date Title
BR9714155A (pt) Prevenção da perda e reposição da massa óssea por certos agonistas de prostaglandina.
BRPI0417006A (pt) administração intraóssea local de agentes de formação de osso e agentes anti-reabsorção e dispositivos para a mesma
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
TR199800767T2 (xx) Proteaz engelleyicileri.
GB0223040D0 (en) Therapeutic compounds
GB0108592D0 (en) Therapeutic agents
ZA9711353B (en) Intramedullary cavity nail for the treatment of fractures of the hip.
AR015946A1 (es) Formulacion farmaceutica que comprende bifosfonatos, proceso para su preparacion, uso de la formulacion para la fabricacion de un medicamento, metodo parala inhibicion de la reabsorcion osea, y metodo para el tratamiento y prevencion de osteoporosis
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
NO972043D0 (no) Tienopyridin eller tienopyrimidinderivater og deres anvendelse
PA8452701A1 (es) Agonistas de prostaglandinas
BR0100558A (pt) Composições e métodos para tratar a osteoporose
PA8475901A1 (es) Terapia de combinacion para la fragilidad musculoesqueletica
AU2002323823A1 (en) Medicament for prevention and treatment of fracture and osteoporosis
PA8471201A1 (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea
PA8472101A1 (es) Combinaciones terapeuticas para la fragilidad musculo esquelectica
BR9808233A (pt) Preparação farmacêutica
HUP0202396A2 (hu) Törések kezelésére alkalmas gyógyszerkészítmények
ECSP993020A (es) Terapia de combinacion para la fragilidad musculoesqueletica
PA8545601A1 (es) Derivados de 4-aminopirimidina
PT1165184E (pt) Antagonismo do receptor-beta do estrogenio e doencas de ossos
BR9904146A (pt) Combinações terapêuticas que incluem um modulador seletivo de receptores de estrogênio e protaglandina e2.
ECSP993021A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
AR013478A1 (es) Metodo para aumentar el volumen oseo.
ECSP993016A (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratoroidea